Compositions comprising HPV polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer
US8137674B2 · kind B2 · utility
5Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 19, 2006 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Sep 24, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/20034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a fusion protein comprising a fusion polypeptide of E6 and E7 of a human papilloma virus, a signal peptide for secreting the polypeptide out of the cell, and an immune enhancing peptide for a subject; a polynucleotide encoding the fusion protein; and a vector containing the polynucleotide. The present invention further relates to a pharmaceutical composition comprising the fusion protein or the vector; and a method for treating a disease caused by a human papilloma virus using the pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.